Loading page...

Back
RFA-CA-27-001 Open
Send to:
National Institutes of Health United States

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

Open

Overview

Funding agency
National Institutes of Health HHS-NIH11
Reference
RFA-CA-27-001
Region
United States
Source
Grants.gov (US Federal)

Description

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits grant applications proposing to develop innovative technologies offering new capabilities for the molecular or cellular characterization of cancer or for improved handling and quality control of biospecimens for basic, clinical, or epidemiological cancer research. The NOFO solicits R61 applications…

Sign up to view full grant details

Create a free account to unlock the complete grant description, funding details, eligibility criteria, and application links.

Full description Funding amounts & eligibility Application links & deadlines Save & track grants

Related grants

Maximizing Investigators’ Research Award (MIRA) for Early Stage Investigators (ESI) National Institutes of Health Advancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional) National Institutes of Health Research Grants in Clinical Informatics (R01 Clinical Trial Optional) National Institutes of Health

Send to CRM

CRM Integration Required

To send grants directly to your CRM, you need to connect your CRM system to TenderPipe first.

Configure CRM in Settings

Email Grant

Scroll to Top